Xiaobing Chen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 6
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 4
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Saiqi Wang (11 shared papers)Minghua Hu (5 shared papers)Beibei Chen (15 shared papers)Xinguang Cao (4 shared papers)Hong‐Min Liu (3 shared papers)Weifeng Xu (9 shared papers)Hongping Xia (5 shared papers)Liangyu Bie (4 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Journal of Clinical Oncology (4 papers)Digestive Diseases and Sciences (3 papers)Frontiers in Pharmacology (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaobing Chen
64 papers receiving 1.5k citations
Xiaobing Chen's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 549
- Molecular Biology 864
- Oncology 266
- Immunology 104
- Organic Chemistry 128
Countries citing papers authored by Xiaobing Chen
This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).
Fields of papers citing papers by Xiaobing Chen
This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Application and synthesis of thiazole ring in clinically approved drugs Hit paper breakdown → | 2023 | 120 |
| 2 | 2011 | 116 | |
| 3 | 2018 | 111 | |
| 4 | 2012 | 71 | |
| 5 | 2009 | 70 | |
| 6 | 2012 | 69 | |
| 7 | 2016 | 59 | |
| 8 | 2015 | 56 | |
| 9 | 2016 | 52 | |
| 10 | 2020 | 41 | |
| 11 | 2010 | 40 | |
| 12 | 2019 | 39 | |
| 13 | 2016 | 38 | |
| 14 | 2020 | 35 | |
| 15 | 2017 | 32 | |
| 16 | 2017 | 30 | |
| 17 | 2021 | 29 | |
| 18 | 2018 | 28 | |
| 19 | 2013 | 28 | |
| 20 | 2019 | 27 |
About Xiaobing Chen
Xiaobing Chen is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA modifications and cancer (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (549 citations), Molecular Biology (864 citations), Oncology (266 citations), Immunology (104 citations) and Organic Chemistry (128 citations). Xiaobing Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Saiqi Wang, Minghua Hu, Beibei Chen, Xinguang Cao, Hong‐Min Liu, Weifeng Xu, Hongping Xia, Liangyu Bie, Honglin Liu and Mingzhi Zhang. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Digestive Diseases and Sciences, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.